Literature DB >> 2568956

Disease associations. Chance, artifact, or susceptibility genes?

N J Cox1, G I Bell.   

Abstract

Numerous genes that might contribute to the development of diabetes mellitus and/or its complications have been isolated and characterized. One approach to determining whether these "candidate" genes influence susceptibility to diabetes is to compare the frequency of a DNA marker(s) (restriction-fragment-length polymorphism) for each gene is appropriately matched groups of patients and control subjects. The identification of a DNA-marker association would suggest that genetic variation at this gene may increase or reduce the risk of developing diabetes. However, the absence of an association does not necessarily imply that this gene does not contribute to the development of diabetes. We discuss the genetic rationale of disease association studies and the importance of sample size and disease-marker allele frequencies in these studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568956     DOI: 10.2337/diab.38.8.947

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

1.  Testing for concordant equilibria between population samples.

Authors:  G A Huttley; S R Wilson
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

Review 2.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian population.

Authors:  M Sten-Linder; S Vilhelmsdotter; A Wedell; I Stern; T Pollare; P Arner; S Efendić; R Luft; H Luthman
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

4.  A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles.

Authors:  K C Chiu; M A Province; G K Dowse; P Z Zimmet; G Wagner; S Serjeantson; M A Permutt
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

5.  Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude.

Authors:  Yue Qi; Wenquan Niu; Tongchun Zhu; Wenyu Zhou; Changchun Qiu
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

6.  Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.

Authors:  T A Chowdhury; M J Dronsfield; S Kumar; S L Gough; S P Gibson; A Khatoon; F MacDonald; B R Rowe; D B Dunger; J D Dean; S J Davies; J Webber; P R Smith; P Mackin; S M Marshall; D Adu; P J Morris; J A Todd; A H Barnett; A J Boulton; S C Bain
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

7.  Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J C Alcolado; M G Baroni; S R Li
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

8.  Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.

Authors:  J Ruiz; H Blanché; N Cohen; G Velho; F Cambien; D Cohen; P Passa; P Froguel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Lack of association of the insulin gene region with type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.

Authors:  C Matsumoto; T Awata; Y Iwamoto; T Kuzuya; T Saito; Y Kanazawa
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

10.  Positive association in the absence of linkage suggests a minor role for the glucokinase gene in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus amongst south Indians.

Authors:  M I McCarthy; M Hitchins; G A Hitman; P Cassell; K Hawrami; N Morton; V Mohan; A Ramachandran; C Snehalatha; M Viswanathan
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.